103
Participants
Start Date
September 16, 2019
Primary Completion Date
January 1, 2020
Study Completion Date
February 1, 2020
nab paclitaxel plus gemcitabine
Nab-paclitaxel 125 mg/m2 weekly for 3 weeks, every 4 weeks Gemcitabine 1000 mg/m2 weekly for 3 weeks, every 4 weeks
Asan Medical Center, Seoul
Lead Sponsor
Bundang CHA Hospital
OTHER
Ulsan University Hospital
OTHER
Asan Medical Center
OTHER